NYSE · LLY
Eli Lilly and Company
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
Loading market information…
OTC · LCDX · USD
Stock price
Quote as of Oct 28, 2026, 03:37 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Caliber Imaging & Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution. Their product line features the VivaScope 1500, a reflectance confocal imaging system that empowers medical practitioners and scientists to capture detailed confocal images depicting the cellular architecture of living tissue. They also provide the VivaScope 3000, a handheld in vivo reflectance confocal microscope tailored for dermatological imaging. Complementing its hardware, the firm offers VivaScan software, which streamlines patient scheduling, facilitates multi-lesion imaging during appointments, and assists with image review and reporting. Additionally, they supply VivaNet, a sophisticated digital telepathology system. Initially established as Lucid, Inc. in 1991, the company rebranded as Caliber Imaging & Diagnostics, Inc. in August 2012 and is headquartered in Andover, Massachusetts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
$275.20+$4.16 (+1.53%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 2.09% below the high.
$0.00$0.00 (0.0%)
Nowauto Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$8.11-$0.31 (-3.68%)
electroCore, Inc.’s quoted price sits in the lower half of its reported 52-week range, 36.14% below the high.
$0.31-$0.02 (-4.82%)
Nano-X Imaging Ltd.’s quoted price sits in the lower half of its reported 52-week range, 93.51% below the high.
$0.73-$0.04 (-4.82%)
Oxbridge Re Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 60.75% below the high.
$0.00$0.00 (0.0%)
TPT Global Tech, Inc.: Technology · Communication Equipment.
$0.00$0.00 (0.0%)
Saltbae Capital Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
